1. Rea TD, Pearce RM, Raghunathan TE et al. Incidence of Out-of-Hospital cardiac arrest. Am J Cardiol 2004; 93: 1455–1460.
2. Straus SM, Bleumink GS, Dieleman JP et al. The incidence of sudden cardiac death in the general population. J Clin Epidemiol 2004; 57: 98–102.
3. Nolan JP, Neumar RW, Adrie C et al. Post-cardiac arrest syndrome: Epidemiology, pathophysiology, treatment, and prognostication: A Scientific Statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; the Council on Stroke. Resuscitation 2008; 79: 350–379.
4. Rosario D. S-100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001; 33: 637–668.
5. Tsoporis JN, Marks A, Haddad A et al. S100B Expression Modulates Left Ventricular Remodeling After Myocardial Infarction in Mice. Circulation 2005; 111: 598–606.
6. Cai XY, Lu L, Wang YN et al. Association of increased S100B, S100A6 and S100P in serum levels with acute coronary syndrome and also with the severity of myocardial infarction in cardiac tissue of rat models with ischemia-reperfusion injury. Atherosclerosis 2011; 217: 536–542.
7. Nagao K, Havashi N, Kanmatsuse K et al. Cardiopulmonary cerebral resuscitation using emergency cardiopulmonary bypass, coronary reperfusion therapy and mild hypothermia in patients with cardiac arrest outside the hospital. J Am Coll Cardiol 2000; 36: 776–783.
8. Raabe A, Grolms C, Sorge O et al. Serum S-100B Protein in Severe Head Injury. Neurosurgery 1999; 45: 477–483.
9. Zongo D, Ribéreau-Gayon R, Masson F et al. S100-B protein as a screening tool for the early assessment of minor head injury. Ann Emerg Med 2012; 59: 209–218.
10. Ruan S, Noyes K, Bazarian JJ et al. The economic impact of S-100B as a pre-head CT screening test on emergency department management of adult patients with mild traumatic brain injury. J Neurotrauma 2009; 26: 1655–1664.
11. Moritz S, Warnat J, Bele S et al. The Prognostic Value of NSE and S100B From Serum and Cerebrospinal Fluid in Patients With Spontaneous Subarachnoid Hemorrhage. J Neurosurg Anesthesiol 2010; 22: 21–31.
12. Nash DL, Bellolio MF, Stead LG. S100 as a Marker of Acute Brain Ischemia: A Systematic Review. Neurocrit Care 2008; 8: 301–307.
13. Ali MS, Harmer M, Vaughan R. Serum S100 protein as a marker of cerebral damage during cardiac surgery. Br J Anaesth 2000; 85: 287–298.
14. Tamura A, Imamaki M, Shimura H et al. Release of serum S-100B protein and neuron-specific enolase after off-pump coronary artery bypass grafting with and without intracranial and cervical artery stenosis. Ann Thorac Cardiovasc Surg 2011; 17: 33–38.
15. Mráček J, Holečková I, Lavička P et al. Vliv neuroprotekce na mozkové metabolické parametry při karotické endarterektomii. Čas Lék Čes 2011; 150: 489–493.
16. Rosén H, Rosengren L, Herlitz J et al. Increased Serum Levels of the S-100 Protein Are Associated With Hypoxic Brain Damage After Cardiac Arrest. Stroke 1998; 29: 473–477.
17. Böttiger BW, Möbes S, Glätzer R et al. Astroglial Protein S-100 Is an Early and Sensitive Marker of Hypoxic Brain Damage and Outcome After Cardiac Arrest in Humans. Circulation 2001; 103: 2694–2698.
18. Lippi G, Aloe R, Numeroso F et al. The significance of protein S-100B testing in cardiac arrest patients. Clin Biochem 2011; 44: 567–575.
19. Derwall M, Stoppe C, Brücken D et al. Changes in S-100 protein serum levels in survivors of out-of-hospital cardiac arrest treated with mild therapeutic hypothermia: a prospective, observational study. Crit Care 2009; 13: R58.
20. Shinozaki K, Oda S, Sadahiro T et al. Serum S-100B is superior to neuron-specific enolase as an early prognostic biomarker for neurological outcome following cardiopulmonary resuscitation. Resuscitation 2009; 80: 870–875.